Jason Grossman
About Jason Grossman
Jason Grossman serves as the Executive Director of Commercial Operations at Geron Corporation, a position he has held since 2022. With extensive experience in the pharmaceutical industry, he has previously worked in various leadership roles at companies such as Stemline Therapeutics and Teva Pharmaceuticals.
Work at Geron
Jason Grossman serves as the Executive Director of Commercial Operations at Geron Corporation, a position he has held since 2022. He operates from the New York City Metropolitan Area, where he focuses on developing and implementing commercial strategies. His role involves overseeing the commercial operations infrastructure, particularly in relation to the launch strategy for Imetelstat in the US.
Previous Experience in Commercial Operations
Prior to his current role, Jason Grossman worked at Stemline Therapeutics, Inc. as the AVP of Global Commercial Operations from 2019 to 2022. He also held various positions at Teva Pharmaceuticals, including Director of Key Account and Trade Management Excellence for Growth Markets and Associate Director of Sales and Marketing Operations for US Generics. His experience spans multiple organizations, including Novartis and Astellas Pharma, where he contributed to oncology sales operations and data governance.
Educational Background
Jason Grossman earned his Master of Business Administration (MBA) with a concentration in Marketing from LaSalle University, completing the program from 1998 to 2001. He also holds a Bachelor of Science degree in Management Science, Marketing, and Sales from Kean College of New Jersey, which he completed from 1990 to 1992. His educational background supports his extensive career in commercial operations and sales analytics.
Achievements and Recognition
Throughout his career, Jason Grossman has been recognized with National Leadership Awards from multiple companies for his outstanding leadership. He has consistently been involved in special projects aimed at skill enhancement beyond his role responsibilities. Additionally, he has a proven track record of creating user-friendly analytical tools from complex data sources to address business challenges.
Key Contributions in Oncology
Jason Grossman played a crucial role in the launch strategy for Imetelstat in the US, focusing on the development of commercial operations infrastructure. His extensive experience in oncology sales and operations has equipped him with the skills necessary to navigate complex market dynamics and drive successful product launches.